Cerebral cortex disorder
MONDO:0044996A disease or disorder that involves the cerebral cortex.
Also known as: cerebral cortex disease, cerebral cortex disease or disorder, disease of cerebral cortex, disease or disorder of cerebral cortex, disorder of cerebral cortex
721 clinical trials for this condition and its sub-types, 0 tagged with Cerebral cortex disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Cerebral cortex disorder
-
Cerebral palsy 441 trials · 497 incl. sub-types
5 sub-types
- Spastic cerebral palsy 75 trials · 228 incl. sub-types Sub-types →
- Athetoid cerebral palsy 6 trials
- Ataxic cerebral palsy 4 trials Sub-types →
- Mixed cerebral palsy 1 trial Sub-types →
- Hypotonic cerebral palsy 0 trials
-
Visual cortex disorder 0 trials · 187 incl. sub-types
2 sub-types
- Visual epilepsy 152 trials Sub-types →
- Cortical blindness 35 trials
-
Pick disease 35 trials
-
Hippocampal sclerosis of aging 3 trials
-
Occipital lobe neoplasm 0 trials
-
Primary motor cortex epilepsy 0 trials
Most studied deeper sub-types
-
Robot suit helps kids with cerebral palsy take steps forward
Disease control Stopped earlyThis study tested whether a robotic exoskeleton could help children aged 6 to 12 with severe cerebral palsy improve their walking and motor skills. Participants used the robot for 45-minute sessions three times a week over six months. The trial aimed to measure changes in movemen…
Sponsor: Hunan Normal University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Botulinum injection trial for arm spasticity halted early
Disease control Stopped earlyThis study tested whether injections of MYOBLOC (botulinum toxin type B) can safely reduce muscle tightness in the arm and hand of adults with spasticity caused by stroke, brain injury, multiple sclerosis, or other conditions. The trial planned to enroll about 300 participants bu…
Phase 2/3 • Sponsor: Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug aims to tame hard-to-control seizures in rare mitochondrial disorders
Disease control Stopped earlyThis study tested a drug called vatiquinone in 68 people with mitochondrial disease and epilepsy that doesn't respond to standard treatments. Participants were randomly assigned to receive either vatiquinone or a placebo for 24 weeks to see if the drug could reduce the number of …
Phase 2/3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Epilepsy drug study halted early: BHV-7000 shows limited promise
Disease control Stopped earlyThis study tested whether BHV-7000, taken alongside other medications, could reduce generalized tonic-clonic seizures in people with idiopathic generalized epilepsy. The trial was terminated early and enrolled only 27 adults aged 18-75. The main goal was to see how long it took f…
Phase 2/3 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Seizure drug study ends early – safety results awaited
Disease control Stopped earlyThis study looked at the long-term safety of an experimental drug called CVL-865 in adults whose focal seizures were not controlled by other medications. About 105 people who completed a previous trial took CVL-865 alongside their usual seizure drugs for up to 57 weeks. The study…
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Seizure drug study halted after just one patient
Disease control Stopped earlyThis study tested the drug perampanel in adults whose seizures did not stop with standard treatments. The goal was to see if it could safely stop seizures and reduce time in the hospital. Only one person enrolled before the study was ended early, so no clear conclusions can be dr…
Phase 4 • Sponsor: Wayne State University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Dravet syndrome drug trial halted early: did lorcaserin help?
Disease control Stopped earlyThis study tested whether lorcaserin, when added to current medications, could reduce convulsive seizures in people with Dravet syndrome, a severe form of epilepsy. The trial planned to enroll about 22 participants aged 2 and older, but it was terminated early. The main goal was …
Phase 3 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can a synthetic cannabinoid calm agitation in frontotemporal dementia?
Symptom relief Stopped earlyThis phase 2 trial tests whether nabilone, a synthetic cannabinoid, can reduce agitation in people with frontotemporal dementia (FTD). Participants receive both nabilone and a placebo in random order to compare effects. The study includes adults with behavioral variant FTD or pri…
Phase 2 • Sponsor: Simon Ducharme, MD • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Can zoom workouts help kids with cerebral palsy get stronger?
Symptom relief Stopped earlyThis study tested whether a 12-week home-based resistance training program, supervised via telehealth, could improve strength and function in children aged 6–15 with cerebral palsy. Participants used elastic bands and weights during live-streamed sessions. The study aimed to see …
Sponsor: Hunan Normal University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Robot suit aims to ease pain for kids with cerebral palsy
Symptom relief Stopped earlyThis study tested whether a motorized orthosis (Innowalk) that mimics walking is better tolerated by children with cerebral palsy than standard standing devices. The trial included 25 children aged 6-16 who had never walked. Researchers measured pain, muscle stiffness, and joint …
Sponsor: Lille Catholic University • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New powered brace aims to improve walking in kids with cerebral palsy
Symptom relief Stopped earlyThis study tested a device called Agilik, a powered leg brace that helps children with cerebral palsy extend their knees while walking. The goal was to see if it improves gait, endurance, and speed. Only 9 children took part, and the study was stopped early, so the results are no…
Sponsor: IRCCS Eugenio Medea • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Botox vs. patch: which stops drooling better in kids with cerebral palsy?
Symptom relief Stopped earlyThis study compared two treatments for drooling in children with cerebral palsy: Botox injections into the salivary glands and scopolamine skin patches. Both groups also received rehabilitation therapy. The goal was to see which treatment reduced drooling more over 15 months. The…
Phase 3 • Sponsor: Hospices Civils de Lyon • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Cooling the brain through the nose: new device tested for ICU fever
Symptom relief Stopped earlyThis study tested a device called CoolStat that is placed in the nose to cool down brain-injured patients with fever in the ICU. The goal was to see if it could safely and quickly bring their temperature to normal. Only 9 patients were enrolled before the study was stopped early,…
Sponsor: CoolTech LLC • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
CBD study for baby seizures halted early
Symptom relief Stopped earlyThis study tested a cannabidiol (CBD) oral solution in children under 2 years old with tuberous sclerosis complex, Dravet syndrome, or Lennox-Gastaut syndrome who had uncontrolled seizures. The goal was to see if CBD is safe and can reduce seizures. However, the study was termina…
Phase 3 • Sponsor: Jazz Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Robots map how brain and nerve injuries disrupt everyday arm tasks
Knowledge-focused Stopped earlyResearchers at the University of Pennsylvania are studying how people with stroke, upper limb amputation, spinal cord injury, or cerebral palsy move their arms during common daily activities like drinking and pouring. The study uses two passive desktop robots to track the motion …
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Gut hormone shot aims to strengthen fragile bones in kids with muscle diseases
Knowledge-focused Stopped earlyThis study tested whether two gut hormones, GIP and GLP-2, could reduce bone breakdown in children with spinal muscular atrophy, cerebral palsy, or Duchenne muscular dystrophy who use wheelchairs. Participants received a liquid meal and then either a hormone injection or a placeb…
Sponsor: University of Copenhagen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Blood protein may predict seizure return, study halted early
Knowledge-focused Stopped earlyThis study looked at whether measuring a protein called S100B in the blood right after a first seizure could help predict if someone will have more seizures within a year. The researchers planned to follow 37 adults for one year, but the study was stopped early. The goal was to f…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC